We are live on ! Find out more
AF

Ally Financial Portfolio holdings

AUM $804M
1-Year Est. Return 0.18%
This Fund
S&P 500
This Quarter Est. Return
+0.03%
1 Year Est. Return
+0.18%
3 Year Est. Return
+8.82%
5 Year Est. Return
+2.15%
10 Year Est. Return
+38.48%
AUM
$505M
AUM Growth
+$61M
Cap. Flow
+$61.9M
Cap. Flow %
12.27%
Top 10 Hldgs %
32.55%
Holding
126
New
24
Increased
34
Reduced
7
Closed
19

Sector Composition

Rank Sector Weight
1 Financials 13.85%
2 Healthcare 13.4%
3 Communication Services 10.68%
4 Technology 9.59%
5 Energy 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
26
Meta Platforms (Facebook)
META
$1.39T
$6.04M 1.2%
40,000
+20,000
+100% +$2.97M
BUD icon
27
AB InBev
BUD
$167B
$5.85M 1.16%
53,000
+6,000
+13% +$687K
TFCFA
28
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$5.38M 1.07%
190,000
KO icon
29
Coca-Cola
KO
$378B
$5.38M 1.07%
120,000
BP icon
30
BP
BP
$115B
$5.37M 1.06%
174,835
-2,914
-2% -$90.7K
MON
31
DELISTED
Monsanto Co
MON
$5.33M 1.06%
45,000
IJR icon
32
iShares Core S&P Small-Cap ETF
IJR
$109B
$5.26M 1.04%
+75,000
New +$5.19M
BAC icon
33
Bank of America
BAC
$436B
$5.22M 1.03%
215,000
+105,000
+95% +$2.45M
GILD icon
34
Gilead Sciences
GILD
$161B
$4.96M 0.98%
70,000
+5,000
+8% +$333K
INTC icon
35
Intel
INTC
$465B
$4.89M 0.97%
145,000
+45,000
+45% +$1.61M
QCOM icon
36
Qualcomm
QCOM
$156B
$4.86M 0.96%
88,000
DIS icon
37
Walt Disney
DIS
$167B
$4.78M 0.95%
+45,000
New +$4.93M
GS icon
38
Goldman Sachs
GS
$302B
$4.66M 0.92%
21,000
+12,000
+133% +$2.67M
IBB icon
39
iShares Biotechnology ETF
IBB
$9.3B
$4.65M 0.92%
+45,000
New +$4.43M
AMGN icon
40
Amgen
AMGN
$207B
$4.31M 0.85%
25,000
+13,000
+108% +$2.11M
OXY icon
41
Occidental Petroleum
OXY
$55.6B
$4.19M 0.83%
70,000
MET icon
42
MetLife
MET
$62.3B
$4.12M 0.82%
84,150
+33,660
+67% +$1.56M
BIIB icon
43
Biogen
BIIB
$30.3B
$4.07M 0.81%
15,000
ORCL icon
44
Oracle
ORCL
$367B
$4.01M 0.79%
80,000
+25,000
+45% +$1.14M
SLB icon
45
SLB Ltd
SLB
$72.9B
$3.95M 0.78%
60,000
AGN
46
DELISTED
Allergan plc
AGN
$3.89M 0.77%
16,000
MCK icon
47
McKesson
MCK
$100B
$3.78M 0.75%
23,000
F icon
48
Ford
F
$57.8B
$3.58M 0.71%
320,000
+65,000
+25% +$726K
RL icon
49
Ralph Lauren
RL
$22.9B
$3.54M 0.7%
48,000
+16,000
+50% +$1.2M
WBA
50
DELISTED
Walgreens Boots Alliance
WBA
$3.52M 0.7%
45,000

Similar funds

Ally Financial's Q2 2017 Portfolio in Review

As of Q2 2017, Ally Financial held 126 positions worth $505M, up 14% from $444M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ally Financial deployed $61.9M of net new capital in Q2 2017, opening 24 new positions and adding to 34 existing holdings. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 305,000 shares worth $12.5M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Vanguard Real Estate ETF, an estimated $10M trimmed.

  • Ally Financial's largest Q2 2017 buy was Vanguard FTSE Emerging Markets ETF: 305,000 shares worth $12.5M.
  • Ally Financial added most to Vanguard FTSE Developed Markets ETF in Q2 2017, an estimated $36.1M increase.
  • Ally Financial's biggest Q2 2017 reduction was Vanguard Real Estate ETF, cutting an estimated $10M.
  • Ally Financial fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2017, selling an estimated $30.3M.
  • Ally Financial's ten largest holdings make up 33% of its $505M portfolio in Q2 2017.
  • Ally Financial opened 24 new positions and closed 19 in Q2 2017.
  • Ally Financial's portfolio value rose 14% quarter-over-quarter to $505M.

Based on Ally Financial's 13F filing for Q2 2017, filed 11 Aug 2017.